VERVE-301

N/A

Report date: 2025/07/16 11:53:45

Base Information

Drug NameVERVE-301
Drug Alias NameGalNAc-LNP Lp(a)VERVE-301
ClassificationCell and gene therapy > Gene therapy > LNPCell and gene therapy > Gene therapy > Gene editing
Mechanisms of ActionApolipoprotein(a) modulators
TargetsApolipoprotein(a)
Therapy Area/IndicationsAtherosclerosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesVerve Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesVerve Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsAtherosclerosis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A